Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06212908
What this trial is testing

Assessment of Periodontal Therapy and Biofilm Management in Breast Cancer

Who this might be right for
Breast CancerGingivitisPeriodontal
University of Sao Paulo 40
Not applicableStudy completedNCT00367588
What this trial is testing

Low Bacterial Diet in Patients With Cytopenia

Who this might be right for
Cytopenia
Maastricht University Medical Center 20
Early research (Phase 1)Ended earlyNCT04702425
What this trial is testing

VOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma)

Who this might be right for
Non-Hodgkin Lymphoma (NHL)Acute Myeloid Leukemia (AML)Multiple Myeloma (MM)
Novartis Pharmaceuticals 37
Not applicableUnknownNCT02900768
What this trial is testing

Effects of Exercise on Allogeneic Stem Cell Transplant

Who this might be right for
Hematological Malignancy
Raewyn Broady 120
Early research (Phase 1)WithdrawnNCT01168882
What this trial is testing

Safety and Tolerability of RGB-286638 in Patients With Selected, Relapsed or Refractory Hematological Malignancies

Who this might be right for
Hematological Malignancies
Agennix
Testing effectiveness (Phase 2)UnknownNCT03366350
What this trial is testing

Anti-CD19 CAR-T Therapy Bridging to HSCT for CD19+ B-Cell Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaB Cell Lymphoma
Wuhan Sian Medical Technology Co., Ltd 50
Testing effectiveness (Phase 2)Study completedNCT02593123
What this trial is testing

Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis

Who this might be right for
Hodgkin's LymphomaLymphoid LeukemiaLymphoma+15 more
Virginia Commonwealth University 31
Not applicableStudy completedNCT02841124
What this trial is testing

Decision to Limit or Withdraw Specific Therapies for Advanced Cancer and Hematological Malignancies.

Who this might be right for
Advanced CancerEthics
Centre Hospitalier Universitaire de Besancon 21
Large-scale testing (Phase 3)UnknownNCT03733340
What this trial is testing

Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT

Who this might be right for
Antibacterial ProphylaxisHematological MalignanciesAllogenetic Hematopoietic Stem Cell Transplantation+1 more
Nanfang Hospital, Southern Medical University 250
Not applicableStudy completedNCT02057185
What this trial is testing

Occupational Status and Hematological Disease

Who this might be right for
Chronic Myeloid LeukemiaChronic Lymphocytic LeukemiaMyelodysplastic Syndrome+2 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 141
Post-approval studies (Phase 4)Looking for participantsNCT03844360
What this trial is testing

Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease

Who this might be right for
Hematological Neoplasms
Wei Zhao 1,500
Large-scale testing (Phase 3)Study completedNCT07671547
What this trial is testing

Prophylaxis of Hematologic Complications With Naderin in First-Line Breast Cancer Chemotherapy

Who this might be right for
Breast CancerHematologic DisorderLeukopenia+1 more
MIPO Clinic 79
Testing effectiveness (Phase 2)Study completedNCT01517035
What this trial is testing

Improving Blood Stem Cell Collection and Transplant Procedures

Who this might be right for
Myelodysplastic Syndrome (MDS)Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 43
Not applicableUnknownNCT04406285
What this trial is testing

Effects of Periodized and Autoregulated Resistance Training in Haematological Cancer Patients During the Treatent.

Who this might be right for
FatigueLeukemiaLymphoma+1 more
Federal University of Health Science of Porto Alegre 66
Not applicableStudy completedNCT04965649
What this trial is testing

Is There an Association Between Innate CD8+ T Cells and the Evolution of Tyrosine Kinase Inhibitor Resistance Mutations in Phi+ Hematological Malignancies.

Who this might be right for
LeukemiaMyelogenous LeukemiaChronic Leukemia+1 more
Centre Hospitalier Universitaire de Nīmes 30
Early research (Phase 1)Study completedNCT04450069
What this trial is testing

CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies

Who this might be right for
Relapsed/Refractory B-cell LymphomasDiffuse Large B Cell Lymphoma (DLBCL)Follicular Lymphoma (FL)+9 more
Calibr, a division of Scripps Research 18
Early research (Phase 1)WithdrawnNCT01235468
What this trial is testing

Allogenic Transplantation of Ex-vivo Expanded Cord Blood (CB)

Who this might be right for
Umbilical Cord BloodStem Cell TransplantationHematological Malignancies
Dr. Avichai Shimoni MD
Very early researchNot Yet RecruitingNCT04662788
What this trial is testing

Clinical Study on the Safety and Effectiveness of NK Cells/Combined Monoclonal Antibodies in the Treatment of Hematological Malignancies

Who this might be right for
Hematological Malignancies
Zhejiang University 36
Not applicableUnknownNCT05364359
What this trial is testing

Individual Dietary Counseling Based on Taste-tests in Patients With Hematological Cancer in Cytostatic Therapy

Who this might be right for
Hematological Malignancy
University of Copenhagen 40
Large-scale testing (Phase 3)Study completedNCT02634294
What this trial is testing

Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT

Who this might be right for
Hematological NeoplasmsRecurrence
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 30
Next Page